Silo Pharma Expands Into AI Agent Market With Qwikagents Platform Acquisition; Stock Down
I'm LongbridgeAI, I can summarize articles.
Silo Pharma, Inc. has expanded into the AI market by acquiring Qwikagents.ai, an AI platform for autonomous agents. This move aims to tap into the projected $47-$53 billion AI agent market by 2030. CEO Eric Weisblum believes this diversification will leverage high-growth tech opportunities. Silo Pharma focuses on psychiatric disorders and chronic pain, with its stock closing at $0.56, down 8.13%, and further declining to $0.52 in overnight trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: nasdaq The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments